GSE226249 pirfenidone HL 2 v 4 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE226249_pirfenidone_HL_2_v_4_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE226249_pirfenidone_HL_2_v_4_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE226249_pirfenidone_HL_2_v_4_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE226249_pirfenidone_HL_2_v_4_human_up.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 5

Gene

GOLGA2 pseudogene 7

Gene

OIP5 antisense RNA 1

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 2693

Gene

HERC2 pseudogene 2

Gene

colorectal neoplasia differentially expressed

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

HOXA transcript antisense RNA, myeloid-specific 1

  • Gene

    small nucleolar RNA host gene 5


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    OIP5 antisense RNA 1


  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 2693


  • Gene

    HERC2 pseudogene 2


  • Gene

    colorectal neoplasia differentially expressed


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    HOXA transcript antisense RNA, myeloid-specific 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.